695 Results for "

compound 2

" in MedChemExpress (MCE) Product Catalog:

Products (695)

Sort by :

Categories

By Targets

Products

Compound 2

Cat. No.: HY-U00358

CAS No.: 872313-42-3

Target:

Drug Derivative

Research Areas:

Metabolic Disease Cancer

Compound 2 is an active compound used for the research of metabolic bone diseases.

Compare

Please select quantity

August 31

Get Quote

View All Sizes

Fumarate hydratase-IN-1

21 Publications Verification

Cat. No.: HY-100004

CAS No.: 1644060-37-6

Purity: 99.14%

Target:

Mitochondrial Metabolism

Research Areas:

Cancer

Fumarate hydratase-IN-1 (compound 2) is a cell-permeable fumarate hydratase inhibitor. Fumarate hydratase-IN-1 has antiproliferative activity against several cancer cell lines with a mean IC₅₀ of 2.2 μM .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

Heme Oxygenase-1-IN-1 hydrochloride

12 Cited Publications

Cat. No.: HY-111798A

CAS No.: 1092851-70-1

Purity: 99.03%

Target:

Reactive Oxygen Species (ROS)

Research Areas:

Cancer

Heme Oxygenase-1-IN-1 (Compound 2) hydrochloride is a heme oxygenase 1 (HO-1) inhibitor with an IC₅₀ of 0.25 μM .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

Heme Oxygenase-1-IN-1

12 Cited Publications

Cat. No.: HY-111798

CAS No.: 1093058-52-6

Purity: 99.11%

Target:

Reactive Oxygen Species (ROS)

Research Areas:

Cancer

Heme Oxygenase-1-IN-1 (compound 2) is a potent heme oxygenase 1 (HO-1) inhibitor, with an IC₅₀ of 0.25 μM. Heme Oxygenase-1-IN-1 can be used for cancer research .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

MAPK-IN-1

6 Cited Publications

Cat. No.: HY-146195

CAS No.: 2470587-69-8

Purity: 95.85%

Target:

Toll-like Receptor (TLR) p38 MAPK JNK ERK Cholinesterase (ChE)

Research Areas:

Neurological Disease Inflammation/Immunology

MAPK-IN-1 (Compound 2) is a MAPK signaling pathway inhibitor. MAPK-IN-1 exhibits AChE inhibitory activity with an IC₅₀ of 23.84 μM. MAPK-IN-1 shows anti-neuroinflammatory and neuroprotective activity and can be used for Alzheimer's disease research .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

LDHA-IN-3

4 Cited Publications

Cat. No.: HY-139319

CAS No.: 227010-33-5

Purity: 99.88%

Target:

Lactate Dehydrogenase

Research Areas:

Cancer

LDHA-IN-3 (compound 2), as a selenobenzene compound, is a potent, noncompetitive lactate dehydrogenase (LDHA) inhibitor (IC₅₀=145.2 nM). LDHA-IN-3 can be used for the research of cancer .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

FEN1-IN-4

3 Cited Publications

Cat. No.: HY-136485

CAS No.: 1995893-58-7

Purity: 99.86%

Target:

FLAP

Research Areas:

Cancer

FEN1-IN-4 (Compound 2) is a human flap endonuclease-1 (hFEN1) inhibitor .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

hPGDS-IN-1

3 Cited Publications

Cat. No.: HY-12791

CAS No.: 1234708-04-3

Purity: 99.92%

Target:

PGE synthase

Research Areas:

Neurological Disease Inflammation/Immunology

hPGDS-IN-1 (Compound 2 ) is an hPGDS inhibitor with an IC₅₀ of 12 nM (as measured by fluorescence polarization assay or EIA). hPGDS-IN-1 can be used in the research of allergic rhinitis and spinal cord neurons .

Compare